Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-432,098
Closed -$3.75M 220
2025
Q1
$3.75M Hold
432,098
0.06% 208
2024
Q4
$5.25M Buy
432,098
+17,134
+4% +$240K 0.08% 196
2024
Q3
$6.98M Buy
414,964
+23,142
+6% +$381K 0.11% 169
2024
Q2
$6.12M Buy
391,822
+14,475
+4% +$201K 0.1% 180
2024
Q1
$5.95M Buy
377,347
+57,280
+18% +$959K 0.1% 184
2023
Q4
$6.44M Buy
320,067
+126,275
+65% +$2.14M 0.11% 174
2023
Q3
$3.59M Buy
+193,792
New +$4.22M 0.07% 203

Other funds holding NEOG

Nicholas Company's NEOG Position: Q2 2025 in Review

Nicholas Company sold out of Neogen (NEOG) in Q2 2025, closing a stake of 432,098 shares — an estimated $3.75M sold.

Nicholas Company first reported a position in NEOG in Q3 2023 and held it in 7 quarters. The position peaked at $6.98M in Q3 2024. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2025.

  • Nicholas Company reported no remaining Neogen position as of Q2 2025 after selling out during the quarter.
  • Nicholas Company sold 432,098 Neogen shares in Q2 2025, an estimated $3.75M.
  • Nicholas Company first reported a position in Neogen in Q3 2023 and held it in 7 quarters.
  • Nicholas Company's Neogen position peaked at $6.98M in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2025.

Based on Nicholas Company's 13F filing for Q2 2025, filed 5 Aug 2025.